Clinical Trial Update: A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TQA3526 in primary biliary cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• TQA3526

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Primary Biliary Cirrhosis | Phase 2 | Status: UNKNOWN